Classification of Childhood Aplastic Anemia and Myelodysplastic Syndrome

被引:78
|
作者
Niemeyer, Charlotte M. [1 ]
Baumann, Irith [2 ]
机构
[1] Univ Med Ctr Freiburg, D-79106 Freiburg, Germany
[2] Clin Ctr South West, Boblingen, Germany
关键词
PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; IMMUNOSUPPRESSIVE THERAPY; REFRACTORY CYTOPENIA; DYSKERATOSIS-CONGENITA; DIAMOND-SYNDROME; MUTATIONS; CHILDREN; LEUKEMIA; GENE; MONOSOMY-7;
D O I
10.1182/asheducation-2011.1.84
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Hypoplastic BM disorders in children and adolescents comprise a broad spectrum of disorders. Acquired severe aplastic anemia (SAA), refractory cytopenia of childhood (RCC), a subtype of myelodysplastic syndrome (MDS), and inherited BM failure (IBMF) disorders are the main and most difficult hematological differential diagnoses. Whereas IBMF disorders can often be diagnosed by their clinical features and/or underlying genetic aberrations, the morphological distinction between SAA and hypocellular RCC has been controversial. The histopathological pattern of RCC consists of islands of immature erythroid precursors accompanied by sparsely distributed granulocytic cells. Megakaryocytes are significantly decreased or absent and, rarely, micromegakaryocytes are detected on immunohistochemistry. Because fatty tissue between areas of hematopoiesis can mimic SAA, 2 biopsies are recommended to facilitate the detection of representative BM spaces. Recent data indicate that the response to immunosuppressive therapy is inferior in RCC compared with SAA. Furthermore, approaches to allogeneic hematopoietic transplantation differ. Controlled prospective clinical studies in patients with hypoplastic BM failure disorders will require comprehensive guidelines for diagnosing SAA, RCC, and the different IBMF disorders.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 50 条
  • [1] Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
    Samarasinghe, Sujith
    Marsh, Judith
    Dufour, Carlo
    [J]. HAEMATOLOGICA, 2014, 99 (04) : 597 - 599
  • [2] Border between aplastic anemia and myelodysplastic syndrome
    Yamazaki, Hirohito
    Nakao, Shinji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 558 - 563
  • [3] Border between aplastic anemia and myelodysplastic syndrome
    Hirohito Yamazaki
    Shinji Nakao
    [J]. International Journal of Hematology, 2013, 97 : 558 - 563
  • [4] Diagnosis and management of aplastic anemia and myelodysplastic syndrome
    Paquette, RL
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (09): : 153 - 161
  • [5] EFFICACY OF ERYTHROPOIETIN ON THE ANEMIA OF MYELODYSPLASTIC SYNDROME AND APLASTIC-ANEMIA
    URABE, A
    MIZOGUCHI, H
    TAKAKU, F
    [J]. EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1172 - 1172
  • [6] Myelodysplastic syndrome and aplastic anemia - diagnostic and conceptual uncertainties
    Barrett, J
    [J]. LEUKEMIA RESEARCH, 2000, 24 (07) : 595 - 596
  • [7] Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
    Stary, J
    Locatelli, F
    Niemeyer, CM
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (Suppl 1) : S13 - S16
  • [8] Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome
    Durrani, Jibran
    Maciejewski, Jaroslaw P.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 97 - 104
  • [9] Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
    J Starý
    F Locatelli
    C M Niemeyer
    [J]. Bone Marrow Transplantation, 2005, 35 : S13 - S16
  • [10] Aplastic Anemia Versus Hypoplastic Myelodysplastic Syndrome: A Diagnostic Dilemma
    Afsari, Ali
    Taddesse-Heath, Lekidelu
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S93 - S93